Envestnet Asset Management Inc Cellectis S.A. Transaction History

Envestnet Asset Management Inc

$302 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 04, 2023	SELL	$1.72 - $2.12 $25,846 - $31,857	-15,027 Reduced 35.05%	27,841 $54,000
Q1 2023 May 11, 2023	SELL	$1.83 - $3.84 $26,679 - $55,983	-14,579 Reduced 25.38%	42,868 $82,000
Q4 2022 Feb 07, 2023	BUY	$1.85 - $2.6 $22,066 - $31,012	11,928 Added 26.2%	57,447 $120,000
Q3 2022 Nov 10, 2022	BUY	$2.29 - $4.08 $56,288 - $100,286	24,580 Added 117.39%	45,519 $104,000
Q2 2022 Aug 03, 2022	BUY	$2.39 - $4.93 $1,046 - $2,159	438 Added 2.14%	20,939 $59,000
Q1 2022 May 04, 2022	BUY	$3.45 - $8.77 $11,402 - $28,984	3,305 Added 19.22%	20,501 $93,000
Q4 2021 Feb 04, 2022	BUY	$8.01 - $12.84 $137,739 - $220,796	17,196 New	17,196 $140,000
Q3 2021 Oct 07, 2021	SELL	$11.94 - $16.09 $761,366 - $1.03 Million	-63,766 Closed	0 $0
Q2 2021 Aug 04, 2021	SELL	$14.36 - $20.93 $169,878 - $247,601	-11,830 Reduced 15.65%	63,766 $986,000
Q1 2021 May 04, 2021	BUY	$18.19 - $33.25 $43,164 - $78,902	2,373 Added 3.24%	75,596 $1.53 Million
Q4 2020 Feb 02, 2021	BUY	$15.87 - $31.64 $108,646 - $216,607	6,846 Added 10.31%	73,223 $1.98 Million
Q3 2020 Oct 09, 2020	SELL	$15.7 - $20.84 $12,418 - $16,484	-791 Reduced 1.18%	66,377 $1.23 Million
Q2 2020 Jul 08, 2020	BUY	$8.21 - $21.02 $41,690 - $106,739	5,078 Added 8.18%	67,168 $1.2 Million
Q1 2020 Apr 23, 2020	BUY	$7.81 - $18.82 $15,698 - $37,828	2,010 Added 3.35%	62,090 $571,000
Q4 2019 Feb 11, 2020	BUY	$9.73 - $19.31 $95,859 - $190,242	9,852 Added 19.61%	60,080 $1.03 Million
Q3 2019 Oct 17, 2019	BUY	$10.15 - $16.89 $92,243 - $153,496	9,088 Added 22.09%	50,228 $522,000
Q2 2019 Aug 02, 2019	SELL	$14.6 - $20.6 $1,460 - $2,060	-100 Reduced 0.24%	41,140 $642,000
Q1 2019 May 10, 2019	BUY	$15.53 - $19.75 $189,916 - $241,522	12,229 Added 42.15%	41,240 $756,000
Q4 2018 Feb 13, 2019	BUY	$15.58 - $28.41 $451,991 - $824,202	29,011 New	29,011 $483,000
Q3 2018 Nov 14, 2018	SELL	$25.99 - $30.6 $337 - $397	-13 Closed	0 $0
Q4 2017 Feb 20, 2018	BUY	$23.33 - $35.01 $303 - $455	13 New	13 $0
Q3 2017 Nov 13, 2017	SELL	$21.65 - $32.18 $281 - $418	-13 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	13	13 $0

Others Institutions Holding CLLS

# of Institutions

Shares Held

10.8M

Call Options Held

5.9K

Put Options Held

1.4K

Long Focus Capital Management, LLC San Juan, PR

4.62M
Shares

$7.2 Million
0.36% of portfolio
Capital International Investors Los Angeles, CA

1.85M
Shares

$2.88 Million
0.0% of portfolio
Credit Suisse Ag Zurich, V8

1.44M
Shares

$2.24 Million
0.0% of portfolio
Ubs Asset Management Americas Inc Chicago, IL

1.44M
Shares

$2.24 Million
0.0% of portfolio
Baillie Gifford & CO

694K
Shares

$1.08 Million
0.0% of portfolio

View Full List

About Cellectis S.A.

Ticker CLLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,510,800
Market Cap $71M
Description
Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. It operates through two segments, Therapeutics and Plants. The company is developing UCART19, an allogeneic T-cell product candidate for the treatm...

More about CLLS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.

Account